Skip to main content
Log in

Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users

  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

This study compared the efficacy of buprenorphine to methadone for decreasing cocaine use in patients with combined opioid and cocaine use. Participants (n=51) were enrolled in a 26-week treatment program and randomly assigned to either buprenorphine or methadone. Dosing was double-blind and double-dummy. Patients were stabilized on either 8 mg sublingual buprenorphine or 50 mg oral methadone, with dose increases given in response to continued illicit cocaine use or opioid use through week 16 of treatment. Maximum doses possible were 16 mg buprenorphine and 90 mg methadone. Average doses achieved were 11.2 mg buprenorphine and 66.6 mg methadone; 49% of the patients received the maximum doses possible. Urine samples were collected three times per week, and there was no significant difference in the rate of cocaine positive urines for the intent-to-treat sample (69% for buprenorphine versus 63% for methadone). For patients who remained in treatment through the flexible dosing period (n=28), there were significant decreases in cocaine positive urines over time (P<0.01), but no significant differences between groups or group × time effects. Buprenorphine and methadone were equally effective on measures of treatment retention, urine results for opioids, and compliance with attendance and counseling. These results demonstrate no selective efficacy of either buprenorphine or methadone in attenuating cocaine use in this population, but do provide further support for the equivalent efficacy of buprenorphine and methadone in the treatment of opioid dependence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ball JC, Ross A (1991) The effectiveness of methadone maintenance treatment. Springer, New York

    Google Scholar 

  • Bickel WK, Stitzer ML, Bigelow GE, Liebson IA, Jasinski DR, Johnson RE (1988) A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts. Clin Pharmacol Ther 43:72–78

    Google Scholar 

  • Brown EE, Finlay JM, Wong JTF, Damsam G, Fibiger HC (1991) Behavioral and neurochemical interactions between cocaine and buprenorphine: implications for the pharmacotherapy of cocaine abuse. J Pharmacol Exp Ther 256:119–126

    Google Scholar 

  • Condelli WS, Fairbank JA, Dennis ML, Rachal JV (1991) Cocaine use in clients in methadone programs: significance, scope and behavioral interventions. J Subst Abuse Treat 8:203–212

    Google Scholar 

  • Crowley TJ, Williams EA, Mikulich SK, Ingersoll NC (1993) Buprenorphine and cocaine effects on social behavior of monkeys. Drug Alcohol Depend 31:235–245

    Google Scholar 

  • Dykstra LA, Doty P, Johnson AB, Picker MJ (1992) Discriminative stimulus properties of cocaine, alone and in combination with buprenorphine, morphine and naltrexone. Drug Alcohol Depend 30:227–234

    Google Scholar 

  • Gastfriend DR, Wapler M, Teoh SK, Reif S, Mendelson JH, Mello NK. (1993) Effects of buprenorphine on needle sharing, drug use and drug craving in men with combined heroin and cocaine dependence. In: Harris LS (ed) Problems of drug dependence 1992 (National Institute on Drug Abuse research monograph 132). Government Printing Office, Washington, DC, p 312

    Google Scholar 

  • Johnson RE, Cone EJ, Henningfield JE, Fudala PJ (1989) Use of buprenorphine in the treatment of opioid addiction. I. Physiologic and behavioral effects during a rapid dose induction. Clin Pharmacol Ther 46:335–343

    Google Scholar 

  • Johnson RE, Jaffe JH, Fudala PJ (1992) A controlled trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts. JAMA 267: 2750–2755

    Google Scholar 

  • Kosten TR, Kleber HD, Morgan C (1989a) Treatment of cocaine abuse with buprenorphine. Biol Psychiatry 26:637–639

    Google Scholar 

  • Kosten TR, Kleber HD, Morgan C (1989b) Role of opioid antagonists in treating intravenous cocaine abuse. Life Sci 44:887–892

    Google Scholar 

  • Kosten TR, Schottenfeld R, Ziedonis D, Falcioni J (1993) Buprenorphine versus methadone maintenance for opioid dependence. J Nerv Ment Dis 181:358–364

    Google Scholar 

  • McLellan AT, Luborsky L, Woody GE, O'Brien CP (1980) An improved diagnostic evaluation instrument for substance abuse patients: the Addiction Severity Index. J Nerv Ment Dis 168:26–33

    Google Scholar 

  • Mello NK, Mendelson JH, Bree MP, Lukas SE (1989) Buprenorphine suppresses cocaine self-administration by rhesus monkeys. Science 245:859–862

    Google Scholar 

  • Mello NK, Lukas SE, Kamien JB, Mendelson JH, Drieze J, Cone EJ (1992) The effects of chronic buprenorphine treatment on cocaine and food self-administration by rhesus monkeys. J Pharmacol Exp Ther 260:1185–1193

    Google Scholar 

  • Mello NK, Kamien JB, Lukas SE, Mendelson JH, Drieze J, Sholar JW (1993) Effects of intermittent buprenorphine administration on cocaine self-administration by rhesus monkeys. J Pharmacol Exp Ther 264:530–541

    Google Scholar 

  • Mendelson JH, Teoh SK, Mello NK, Ellingboe J (1992) Buprenorphine attenuates the effects of cocaine on adrenocorticotropin (ACTH) secretion and mood states in man. Neuropsychopharmacology 7:157–162

    Google Scholar 

  • Rawson RA, Obert JL, McCann MJ, Castro FG, Ling W (1991) Cocaine abuse treatment: a review of current strategies. J Subst Abuse 3:457–491

    Google Scholar 

  • Rosen MI, Pearsall HR, McDougle CJ, Price LH, Woods SW, Kosten TR (1993) Effects of acute buprenorphine on responses to intranasal cocaine. In: Harris LS (ed) Problems of drug dependence 1992 (National Institute on Drug Abuse research monograph 132). Government Printing Office, Washington, DC, p 340

    Google Scholar 

  • Spitzer RL, Williams JBW (1985) Structured clinical interview for DSM-III-R. New York State Psychiatric Institute, Biometrics Research, New York

    Google Scholar 

  • Strain EC, Stitzer ML, Liebson IA, Bigelow GE (1993) Dose-response effects of methadone in the treatment of opioid dependence. Ann Int Med 119:23–27

    Google Scholar 

  • Strain EC, Stitzer ML, Liebson IA, Bigelow GE (1994a) The effects of cocaine in buprenorphine maintained outpatient volunteers: Results from clinical experience and laboratory challenges. Am J Addict 3:129–143

    Google Scholar 

  • Strain EC, Stitzer ML, Liebson IA, Bigelow GE (1994b) Comparison of buprenorphine to methadone in the treatment of opioid dependence. Am J Psychiatry 151:1025–1030

    Google Scholar 

  • Teoh SK, Sintavanarong P, Kuehnle J, Mendelson JH, Hallgring E, Rhoades E, Mello NK (1993) Buprenorphine's effects on morphine and cocaine challenges in heroin and cocaine dependent men. In: Harris LS (ed) Problems of drug dependence 1992 (National Institute on Drug Abuse research monograph 132). Government Printing Office, Washington, DC, p 460

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Strain, E.C., Stitzer, M.L., Liebson, I.A. et al. Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users. Psychopharmacology 116, 401–406 (1994). https://doi.org/10.1007/BF02247469

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02247469

Key words

Navigation